Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence of fluticasone propionate via Novolizer vs Diskus in mild to moderate persistent asthma
2005-001729-26Phase 3Completed
- Sponsor
- Viatris
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Flutide mite 100 Diskus, Fluticasone Novolizer and Placebo Novolizer (3 arms). Primary endpoint: Morning pre-dose FEV1. Started Aug 2005; status: completed.
02
Drugs
fluticasone propionatefluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-001729-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001729-26.